Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • heart failure

    Tag: heart failure

    You Searched For "heart failure"
    Dr Reddys suspends worldwide supply of Ranitidine over cancer fears until USFDA probe over

    Dr Reddys suspends worldwide supply of Ranitidine over cancer fears until USFDA probe over

    Medical Dialogues Bureau23 Sept 2019 4:30 AM
    Ranitidine is an Over-The-Counter (OTC) and prescription drug which decreases the amount of acid created by the stomach.Hyderabad: Dr Reddy's...
    Novartis CEO sets aside 700 Million Dollar to settle doctor bribery lawsuit

    Novartis CEO sets aside 700 Million Dollar to settle doctor bribery lawsuit

    Medical Dialogues Bureau20 July 2019 4:22 AM
    ZURICH: Novartis Chief Executive Vas Narasimhan set aside $700 million to settle a U.S. doctor bribery lawsuit, as the Swiss drugmaker seeks to close...
    Pfizer gets USFDA approval for Vyndaqel, Vyndamax to treat amyloidosis cardiomyopathy

    Pfizer gets USFDA approval for Vyndaqel, Vyndamax to treat amyloidosis cardiomyopathy

    Farhat Nasim11 May 2019 3:45 AM
    New Delhi: Pfizer Inc's subsidiary FoldRx, has recently won U.S. Food and Drug Administration (USFDA) approved for Vyndaqel (tafamidis meglumine) and...
    CDSCO Committee rejects proposal for additional Indications of Dapaglofizin

    CDSCO Committee rejects proposal for additional Indications of Dapaglofizin

    Meghna A Singhania5 May 2019 7:22 AM
    New Delhi: British-Swedish multinational drugmaker, AstraZeneca's stride to win approval from the Indian drug regulators for the additional...
    Alchem solves stability dilemma for micronized DIGOXIN; files PATENT for novel production process

    Alchem solves stability dilemma for micronized DIGOXIN; files PATENT for novel production process

    Meghna A Singhania16 April 2019 11:17 AM
    Alchem's molecule is the sole micronized digoxin available globally that resolves the challenge of micro dosage formulation and the long-term...
    Omron Healthcare to introduce COMPLETE, first BP monitor with EKG capability

    Omron Healthcare to introduce COMPLETE, first BP monitor with EKG capability

    Farhat Nasim15 April 2019 3:50 AM
    Complete is an upper arm blood pressure (BP) monitor that allows users to simultaneously monitor EKG and blood pressure readings at home. U.S: Omron...
    Bayer, Johnson and Johnson

    Bayer, Johnson and Johnson's heart drug Xarelto fails trial to widen use

    Ruby Khatun Khatun28 Aug 2018 4:15 AM
    FRANKFURT: Bayer and Johnson and Johnson's campaign to widen the market for its heart drug Xarelto hit a snag on Sunday when a study for a potential...
    Tiny stem cell companies close in on major heart disease goals

    Tiny stem cell companies close in on major heart disease goals

    Ruby Khatun Khatun20 Dec 2017 4:00 AM
    NEW YORK: The early hope that stem cell therapy would make the paralyzed walk, the blind see and cure diabetes has given way to a long list of...
    Zydus Cadila gets USFDA nod for swelling reducing drug

    Zydus Cadila gets USFDA nod for swelling reducing drug

    Ruby Khatun Khatun20 Nov 2017 4:32 AM
    New Delhi: Zydus Cadila has received final approval from the US health regulator to market Ethacrynate sodium for injection, used to reduce swelling...

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok